共 52 条
- [1] UPADHYAY J, FARR 0, PERAKAKIS N, Et al., Obesity as a disease, Medical Clinics, 102, 1, pp. 13-33, (2018)
- [2] KOTSIS V, TSIOUFIS K, ANTZA C, Et al., Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High —risk Patient and European Association for the Study of Obesity: Part B
- [3] Obesity -induced cardiovascular disease, early prevention strategies and future research directions, Journal of Hypertension, 36, 7, pp. 1441-1455, (2018)
- [4] SHARMA M, LI Y, STOLL M L, Et al., The epi-genetic connection between the gut microbiome in obesity and diabetes, Frontiers in Genetics, 10, (2020)
- [5] MATSUDA M, SHIMOMURA I., Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer, Obesity Research & Clinical Practice, 7, 5, pp. e330-e341, (2013)
- [6] XU J B, MA Z, LI X P, Et al., A more pronounced effect of type III resistant starch vs. type II resistant starch on ameliorating hyperlipidemia in high fat diet -fed mice is associated with its supramolecular structural characteristics, Food & Function, 11, 3, pp. 1982-1995, (2020)
- [7] POLYZOS S A, KOUNTOURAS J, MANTZOROS C S., Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics, Metabolism, 92, 3, pp. 82-97, (2019)
- [8] WASEEM M, HUSAIN H, AHMAD I., Role of gene polymorphism in obesity and cancer [M], Obe sity and Cancer, pp. 129-142, (2021)
- [9] Obesity and overweight [EB/OL]
- [10] MULLER M J, GEISLER C., Defining obesity as a disease, European Journal of Clinical Nutrition, 71, 11, pp. 1256-1258, (2017)